How can I lower my triglyceride levels?

How to Reduce Triglycerides

Lifestyle interventions are the first-line therapy for all patients with elevated triglycerides, with weight loss being the single most effective intervention—a 5-10% reduction in body weight can lower triglycerides by 20-70%. 1

Algorithmic Approach to Triglyceride Reduction

Step 1: Lifestyle Modifications (First-Line for ALL Patients)

Weight Loss (Most Effective)

• Target a 5-10% reduction in body weight for a 20% decrease in triglycerides 1
• Some patients achieve up to 70% triglyceride reduction with weight loss, though response is variable 1
• Even 3-5% sustained weight loss produces clinically meaningful benefits 1
• A dose-response relationship exists: more weight lost = greater triglyceride lowering 1

Dietary Modifications (Can achieve >70% reduction) 1

The macronutrient composition matters significantly:

• Reduce carbohydrates, especially refined carbohydrates and sugar-sweetened beverages 2, 3

  • Very low-carbohydrate diets (<10% of calories) produce the greatest triglyceride reduction: 24 mg/dL decrease 1
  • Low-carbohydrate diets (20% energy) reduce triglycerides by 18% 1
  • Fructose in sweetened beverages may raise triglycerides more than glucose 2

• Increase healthy fats 2, 3

  • Replace carbohydrates with monounsaturated or polyunsaturated fats
  • Omega-3 fatty acids uniquely lower triglycerides among all fatty acid types 2
  • Increase fish intake, particularly omega-3 rich fish (>800 mg long-chain omega-3/100g) 4

• Restrict or completely abstain from alcohol 1, 2

• Avoid trans fats and minimize saturated fats 5

Physical Activity

• 30-60 minutes of aerobic or mild resistance exercise dampens postprandial triglyceride increases 2
• High-intensity aerobic programs show more favorable effects than low-intensity 2
• Combination of aerobic and resistance exercise may be superior to aerobic alone in men 2

Step 2: Address Secondary Causes

• Optimize glycemic control in diabetes 6
• Review and modify medications that raise triglycerides
• Treat underlying conditions contributing to hypertriglyceridemia 2

Step 3: Pharmacologic Therapy (Based on Triglyceride Level and Cardiovascular Risk)

For Triglycerides 150-499 mg/dL (Moderate Hypertriglyceridemia):

1. Calculate 10-year ASCVD risk to guide medication decisions 3

2. Statins are first-line for patients with:

   • Borderline risk (5-7.4%) or intermediate risk (7.5-19.9%) 3
   • Elevated cardiovascular risk 6

3. For patients on maximally tolerated statin with persistent elevation and high cardiovascular risk:

   • Icosapent ethyl (purified EPA) 4g daily is the only agent proven to reduce cardiovascular events 6, 3
   • REDUCE-IT trial showed 21.6% triglyceride reduction and 26.1% reduction in cardiovascular events 5
   • NNT = 111 to prevent one cardiovascular death over 5 years 3

4. Alternative agents (fibrates, niacin, omega-3 fatty acids) may be considered but lack strong cardiovascular outcome data 2, 6

For Triglycerides ≥500 mg/dL (Severe Hypertriglyceridemia - Pancreatitis Risk):

1. Fibrates as first-line pharmacologic agent to reduce pancreatitis risk 2

2. Prescription omega-3 preparations (EPA/DHA combinations) are FDA-indicated as adjunct to diet 1

3. Consider combination therapy with fibrates, niacin, or omega-3 fatty acids 2

4. Severely restrict dietary fat initially, particularly in lipoprotein lipase deficiency 2

Critical Pitfalls to Avoid

• Don't assume all omega-3 products are equal: Only icosapent ethyl (purified EPA) has proven cardiovascular benefit; combined EPA/DHA products have not shown the same outcomes 6

• Don't prioritize low-fat, high-carbohydrate diets: These actually lessen triglyceride reduction compared to higher-fat, lower-carbohydrate approaches 1

• Don't overlook alcohol: Complete abstinence may be necessary, as alcohol is a major contributor to hypertriglyceridemia 1, 2

• Don't use triglyceride-lowering therapy without addressing lifestyle first: Lifestyle modifications can achieve >70% reduction and are foundational 1

Nuances in the Evidence

The 2021 ACC Expert Consensus 1 provides the most comprehensive and recent algorithmic approach, emphasizing that lifestyle interventions must be individualized to target the specific triggers (obesity, poor diet, sedentary lifestyle, alcohol) most relevant to each patient. The evidence strongly supports carbohydrate restriction over fat restriction for triglyceride lowering, which contradicts older dietary recommendations.

While multiple drug classes exist, only icosapent ethyl has demonstrated cardiovascular outcome benefit in the REDUCE-IT trial 6, 5. Other agents (fibrates, niacin, combined EPA/DHA) have failed to show cardiovascular benefit in clinical trials despite lowering triglycerides 6. This highlights that triglyceride lowering alone may not translate to improved outcomes unless the right mechanism is targeted.

For severe hypertriglyceridemia (≥500 mg/dL), the primary goal shifts to pancreatitis prevention, where fibrates are recommended first-line despite lack of trial evidence for this specific outcome 2.